Peter MacCallum Centre of Excellence in Cellular Immunotherapy

We are excited to hear about the latest funding boost to Peter MacCallum Cancer Institute to become a Centre of Excellence in CAR T-Cell therapy.  More patients will soon have access to life-changing immunotherapy clinical trials thanks to a $105 million co-investment announced by Greg Hunt MP and the Commonwealth Government.

This significant $80 million government investment, with input from Peter Mac and the Peter Mac Foundation, will provide access to treatments previously only offered overseas, making Melbourne a global hub for immunotherapy.

As with other cancer types, we hold out hope that this therapy could be manipulated and researched to have effect on NET cancers.

Read news story from Peter Mac here

Peter Mac

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.